TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1655261

Group type: EXPERIMENTAL
Intervention: Lisinopril monotherapy, 10, 20, or 40 mg once daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Captopril monotherapy, 25, 50, or 100 mg twice daily
Number of subjects: 70
Study: 6603654

Group type: EXPERIMENTAL
Intervention: Trimethoprim and methenamine hippurate (TMP + MH) at 100 + 500 mg b.i.d.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Trimethoprim and methenamine hippurate (TMP + MH) at 200 + 1000 mg b.i.d.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Plain Trimethoprim (TMP) at 200 mg b.i.d.
Number of subjects: 160

Group type: COMPARATOR
Intervention: TMP-sulfamethoxazole combination at 160 mg + 800 mg b.i.d.
Number of subjects: 160
Study: 30669665

Group type: EXPERIMENTAL
Intervention: High impact group (Zumba®)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Low impact group (Aquagym)
Number of subjects: 55
Study: 30346610

Group type: EXPERIMENTAL
Intervention: Theory of planned behavior (TPB)‐driven concussion education program
Number of subjects: 428

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 428
Study: 27829445

Group type: EXPERIMENTAL
Intervention: Community-based intervention program integrating HIV-testing and treatment services, ECCD, and nutrition education for caregivers, consisting of nine group-based sessions over 12 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 0
Study: 24281754

Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon (PCB) angioplasty
Number of subjects: 479
Study: 22272347

Group type: EXPERIMENTAL
Intervention: Experimental group undergoing a classical DRM design
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group without DRM manipulation
Number of subjects: 60
Study: 19661796

Group type: EXPERIMENTAL
Intervention: Breast Cancer Education Intervention (BCEI) consisting of 3 face-to-face education and support sessions and 2 face-to-face and 3 telephone follow-up sessions over 6 months.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Wait-control group receiving 3 face-to-face sessions and 3 telephone sessions without the BCEI intervention.
Number of subjects: 53
Study: 18380843

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) applied parallel to gravity (1A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) applied perpendicular to gravity (1B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB2.1) applied parallel to gravity (2A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB2.1) applied perpendicular to gravity (2B)
Number of subjects: 24
Study: 15942297

Group type: EXPERIMENTAL
Intervention: Moderate-severe OSA (AHI >= 15)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Mild OSA (AHI 5-14)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (AHI <5)
Number of subjects: 49
Study: 11914189

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 0
Study: 10424180

Group type: EXPERIMENTAL
Intervention: Small capacity chainsaw
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Medium capacity chainsaw
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Large capacity chainsaw
Number of subjects: 11
Study: 7571047

Group type: EXPERIMENTAL
Intervention: Doxifluridine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluorouracil with folinic acid
Number of subjects: 0
Study: 2125242

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg once daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxiracetam (800 mg twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxiracetam
Number of subjects: 40
Study: 6778330

Group type: EXPERIMENTAL
Intervention: Oral decongestant (pseudoephedrine hydrochloride)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination (pseudoephedrine hydrochloride and chlorpheniramine maleate)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31405402

Group type: EXPERIMENTAL
Intervention: GCBT plus duloxetine
Number of subjects: 170

Group type: COMPARATOR
Intervention: Duloxetine alone
Number of subjects: 170
Study: 29444769

Group type: EXPERIMENTAL
Intervention: Living with Deadly Thoughts (online self-help intervention)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Living Well (attention-matched control program)
Number of subjects: 418
Study: 26873498

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 20
Study: 25300435

Group type: EXPERIMENTAL
Intervention: Cardiosphere-derived cells (CDCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depletion of CD90(+) cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD90(‐) CDCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: c-kit(+) cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: c-kit expression
Number of subjects: 0
Study: 22548300

Group type: EXPERIMENTAL
Intervention: Serious video game designed to remediate attitudinal, behavioural and emotional processes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biofeedback component of the video game
Number of subjects: 0
Study: 20109170

Group type: EXPERIMENTAL
Intervention: Involvement in the criminal justice system
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Victim of a crime
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: On parole or probation
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Cost of involvement
Number of subjects: 609
Study: 17081540

Group type: EXPERIMENTAL
Intervention: IV tramadol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 16234105

Group type: EXPERIMENTAL
Intervention: Jianpikangfu decoction in combination with western medicine treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Exclusive western medicine treatment
Number of subjects: 45
Study: 12454299

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical muscle stimulation (TCEMS) of the lower extremities, performed three times a week for 20 minutes each session for six weeks.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham treatment (control group).
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical muscle stimulation (TCEMS) of the lower extremities.
Number of subjects: 18
Study: 10336003

Group type: EXPERIMENTAL
Intervention: TT virus DNA detection in donors with elevated ALT levels (mean ALT 89.3 U/L)
Number of subjects: 861

Group type: COMPARATOR
Intervention: TT virus DNA detection in donors with normal ALT levels (<= 45 U/L)
Number of subjects: 861
Study: 7487244

Group type: EXPERIMENTAL
Intervention: Enalaprilat 0.625 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Enalaprilat 1.25 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Enalaprilat 2.5 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Enalaprilat 5 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Enalaprilat (all doses)
Number of subjects: 65
Study: 1793725

Group type: EXPERIMENTAL
Intervention: Induction treatment with electrically stimulated lymphatic drainage (group B)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Elastic sleeve only (group A)
Number of subjects: 74
Study: 7074796

Group type: EXPERIMENTAL
Intervention: Dobutamine treatment (4-hour infusions weekly for 24 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study: 31816038

Group type: EXPERIMENTAL
Intervention: Empagliflozin (E) 10 mg with Linagliptin (L) 5 mg once daily
Number of subjects: 97

Group type: COMPARATOR
Intervention: Metformin (M) 850 or 1000 mg twice daily with Insulin Glargine (I) once daily
Number of subjects: 97
Study: 29787937

Group type: EXPERIMENTAL
Intervention: Working memory training using the CogMed program (20 to 25 computerised 25-min sessions over 5-7 weeks)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 452
Study: 27268312

Group type: EXPERIMENTAL
Intervention: Clopidogrel use within 5 days of surgery
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: PRU <170
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Clopidogrel users
Number of subjects: 79
Study: 24368640

Group type: EXPERIMENTAL
Intervention: Open dissection tunnel EVH device
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Closed dissection tunnel EVH device
Number of subjects: 1549
Study: 24030269

Group type: COMPARATOR
Intervention: Quality Improvement Intervention at Health Centres (FI)
Number of subjects: 14576

Group type: COMPARATOR
Intervention: Community Intervention (CI)
Number of subjects: 14576

Group type: COMPARATOR
Intervention: Combined Intervention (FI + CI)
Number of subjects: 14576

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 14576
Study: 20578537

Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day for 3 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 19012623

Group type: EXPERIMENTAL
Intervention: 20% n‐CAP for 50 strokes (2-day use)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Various concentrations of n‐CAP
Number of subjects: 100
Study: 16640806

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel (100 mg/m2) and carboplatin (AUC 2) once weekly for 6-8 weeks (arm A)
Number of subjects: 883

Group type: COMPARATOR
Intervention: Every-3-week paclitaxel (200 mg/m2) and carboplatin (AUC 6) on day 1 every 21 days (arm B)
Number of subjects: 883
Study: 12871402

Group type: EXPERIMENTAL
Intervention: Atorvastatin + omega-3 fatty acids (1.68 g day(‐1))
Number of subjects: 42

Group type: COMPARATOR
Intervention: Atorvastatin + placebo (corn oil)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 42
Study: 10976127

Group type: EXPERIMENTAL
Intervention: Tourniquet inflated
Number of subjects: 109

Group type: COMPARATOR
Intervention: Tourniquet not inflated
Number of subjects: 109
Study: 8604912

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole intravenously (CIP/MTZ IV)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole intravenously and orally (CIP/MTZ IV/PO)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Imipenem/cilastatin intravenously (IMI IV)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole orally (CIP/MTZ IV/PO)
Number of subjects: 671
Study: 1415526

Group type: EXPERIMENTAL
Intervention: 6 mo rhGH
Number of subjects: 10

Group type: COMPARATOR
Intervention: 6 mo placebo
Number of subjects: 10
Study: 3971104

Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous mezlocillin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no mezlocillin)
Number of subjects: 100
Study: 30451243

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125%/fentanyl 5.0 μg/mL
Number of subjects: 94

Group type: COMPARATOR
Intervention: Ropivacaine 0.2%/fentanyl 5.0 μg/mL
Number of subjects: 94
Study: 27982546

Group type: EXPERIMENTAL
Intervention: 5% permethrin cream applied once daily for two consecutive days (group 2)
Number of subjects: 89

Group type: COMPARATOR
Intervention: 5% permethrin cream applied once daily (group 1)
Number of subjects: 89
Study: 26283736

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 20
Study: 24641640

Group type: EXPERIMENTAL
Intervention: Continuous transversus abdominis plane analgesia (n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Epidural analgesia (n = 35)
Number of subjects: 70
Study: 22158697

Group type: EXPERIMENTAL
Intervention: '6D Cards'
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual discussion processes (Control)
Number of subjects: 140
Study: 20454812

Group type: EXPERIMENTAL
Intervention: OCT parameters in patients with MDR
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: OCT parameters in patients without MDR
Number of subjects: 102

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mean HbA1c, microalbuminuria, cholesterol levels, triglycerides, hypertension prevalence, age at diagnosis, diabetes duration
Number of subjects: 102
Study: 17873684

Group type: EXPERIMENTAL
Intervention: Citicoline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 15806747

Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Number of subjects: 0
Study: 11908577

Group type: EXPERIMENTAL
Intervention: High Intensity Fitness Training (HIF)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Low Intensity Fitness Training (LIF)
Number of subjects: 37
Study: 10101739

Group type: EXPERIMENTAL
Intervention: Single i.v. bolus of 50 micrograms GHRH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Five 'repetitive' boluses of 10 micrograms GHRH
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8569272

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasonography (TVU)
Number of subjects: 33
Study: 1934418

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 468

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 468
Study: 839327

Group type: COMPARATOR
Intervention: Formula 1 (F1) = 1.5 gm/dl protein, 60 parts bovine whey proteins: 40 parts bovine caseins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula 2 (F2) = 3.0 gm/dl, 60:40
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula 3 (F3) = 1.5 gm/dl, 18:82
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula 4 (F4) = 3.0 gm/dl, 18:82
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pooled human milk (BM)
Number of subjects: 0
Study: 31743617

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 31133627

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Multi‐Theory Model (MTM)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 94
Study: 28690144

Group type: EXPERIMENTAL
Intervention: Preoperative conventional chemoradiotherapy (CRT) with delayed surgery (50Gy/25 fr with fluorouracil and leucovorin on the 1st and 5th week of RT followed by TME surgery in 6-8 weeks and 4 cycles of adjuvant fluorouracil/leucovorin every 4 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Preoperative short-course radiotherapy (SCRT) with delayed surgery (25Gy/5 fr followed by TME surgery in 6-8 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preoperative conventional chemoradiotherapy (CRT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Preoperative short-course radiotherapy (SCRT)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preoperative conventional chemoradiotherapy (CRT) in intent-to-treat (ITT) population
Number of subjects: 150

Group type: COMPARATOR
Intervention: Preoperative short-course radiotherapy (SCRT) in intent-to-treat (ITT) population
Number of subjects: 150
Study: 24621355

Group type: EXPERIMENTAL
Intervention: Dietary modification intervention programme (8 weeks duration)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 68
Study: 23796359

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus R0011 1.9×10(9) cfu and Lactobacillus acidophilus R0052 0.1×10(9) cfu)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 17086775

Group type: EXPERIMENTAL
Intervention: Thermoneutral head‐out water immersion (34.5 degrees C)
Number of subjects: 26
Study: 15280147

Group type: EXPERIMENTAL
Intervention: Acidic vaginal gel (Miphil), 2.5 g every 3 days for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acidic vaginal gel (Miphil)
Number of subjects: 70
Study: 10716137

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 9361939

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 mg twice a day for the first 10 days, then 250 mg/day for 6 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 80
Study: 1336892

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg administered as a single daily dose for 3 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amoxycillin/clavulanic acid (50 mg/kg/day given b.i.d. for 10 days)
Number of subjects: 30
Study: 3987546

Group type: EXPERIMENTAL
Intervention: Intravenous felodipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose oral felodipine (0.10 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose oral felodipine (0.01 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects (placebo comparison)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypertensive patients (placebo comparison)
Number of subjects: 0
Study: 31993993

Group type: EXPERIMENTAL
Intervention: Primary anastomosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hartmann's procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoidectomy
Number of subjects: 0
Study: 30277930

Group type: EXPERIMENTAL
Intervention: Intravenous methylnaltrexone
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 27859410

Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 26024831

Group type: EXPERIMENTAL
Intervention: Bicalutamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 0
Study: 24419299

Group type: EXPERIMENTAL
Intervention: Increasing BMI
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Increasing BMI (more overweight group, n = 19; BMI 27.5-30 kg/m²)
Number of subjects: 38
Study: 21978432

Group type: EXPERIMENTAL
Intervention: Acellular human dermal matrix augmentation (GraftJacket)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No augmentation
Number of subjects: 42
Study: 19465231

Group type: EXPERIMENTAL
Intervention: Intensive glycaemic control
Number of subjects: 33040
Study: 17967640

Group type: EXPERIMENTAL
Intervention: Midazolam 0.075 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 90
Study: 12972442

Group type: EXPERIMENTAL
Intervention: Low-volume/moderate-intensity group (approximately 12 miles walking/wk at 40-55% peak O2 consumption)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: High-volume/high-intensity group (approximately 20 miles jogging/wk at 65-80% peak O2 consumption)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Low-volume/high-intensity group (approximately 12 miles jogging/wk at 65-80% peak O2 consumption)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 154
Study: 11591187

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9624757

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 8089543

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (40 mg orally four times a day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg orally three times a day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (1 tablet orally three times a day)
Number of subjects: 52
Study: 2819522

Group type: EXPERIMENTAL
Intervention: Infant cry
Number of subjects: 32

Group type: COMPARATOR
Intervention: Smoke alarm
Number of subjects: 32
Study: 31337371

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 0
Study: 28357673

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Validation dataset from Nanfang Hospital (n = 135)
Number of subjects: 201
Study: 24168840

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy Scale (CTS)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: ACE Treatment Integrity Measure (ATIM)
Number of subjects: 62
Study: 22644743

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (pretreatment)
Number of subjects: 50
Study: 21703000

Group type: EXPERIMENTAL
Intervention: Telephone administration of CRIS measure
Number of subjects: 102

Group type: COMPARATOR
Intervention: In-person administration of CRIS measure
Number of subjects: 102
Study: 17901881

Group type: EXPERIMENTAL
Intervention: logMAR crowded Kay picture test
Number of subjects: 51

Group type: COMPARATOR
Intervention: crowded logMAR acuity test
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: uncrowded logMAR acuity test
Number of subjects: 51
Study: 16682309

Group type: EXPERIMENTAL
Intervention: Aerobic training (group T) for nine months at 60% of maximal oxygen uptake (VO2)
Number of subjects: 95

Group type: COMPARATOR
Intervention: No training (group C)
Number of subjects: 95
Study: 14996470

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-Aspirin
Number of subjects: 24
Study: 11555764

Group type: EXPERIMENTAL
Intervention: Nebulized topical saline‐tobramycin solution administered thrice daily for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline‐only solution administered thrice daily for 4 weeks
Number of subjects: 20
Study: 9402446

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering drugs (mostly simvastatin at an average dose of 14 mg/day)
Number of subjects: 785

Group type: COMPARATOR
Intervention: No cholesterol lowering drugs (non-users)
Number of subjects: 785